Caffeine in Children With Obstructive Sleep Apnea, Dose Response Study
Status:
Terminated
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate whether a smaller dose of caffeine sodium benzoate 10
mg/kg IV is as effective as 20 mg/kg IV in decreasing the number of children who develop post
extubation adverse upper airway respiratory events compared to placebo.
Phase:
N/A
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston
Collaborator:
Memorial Hermann Hospital
Treatments:
Caffeine Caffeine, sodium benzoate drug combination Sodium Benzoate